adiposity. Our aim was to determine the association between ultrasound biometry and adiposity measurements at 36 weeks gestation and neonatal body composition. Methods: Data were derived from the LIMIT trial involving 2212 women entering pregnancy overweight or obese. Fetal biometry, estimated fetal weight (EFW) and adiposity ultrasound measurements including mid-thigh fat mass (MTFM), subscapular fat mass (SSFM), abdominal fat mass (AFM) were measured using ultrasound at 36 weeks gestation in 845 women from the Standard Care group. Neonatal measurements were obtained in the postpartum period including birthweight, head circumference (HC), abdominal circumference (AC), subscapular skinfold thickness, and abdominal skinfold thickness. Results: After adjusting for time between ultrasound and birth measures every 1 gram increase in EFW at 36 weeks was associated with a 0.94 gram increase in birthweight (95% CI 0.88 to 0.99 grams; P < 0.001). The combination of EFW at 36 weeks and time between the ultrasound and birth, explain 63% of the overall variability in birthweight. Every 1 mm increase in HC at 36 weeks was associated with a 0.69 mm increase in HC measured at birth (95% CI 0.63 to 0.75 grams, P < 0.001). Every 1 mm increase in AC at 36 weeks was associated with a 0.69 mm increase in AC measured at birth (95% CI 0.60 to 0.79 mm, P < 0.001). st (IG-21) formula was derived using an international population and may be more generalisable than the American derived Hadlock formula, but additional validation is needed. This study compared accuracy of estimated birthweights (EBWs) using both formulas from 3rd trimester scans in the obese. Methods: A retrospective chart review of obese patients (BMI>30) with 3rd trimester scans (28w5d-38w6d) delivered at two urban hospitals from 4/2013-2/2017 was performed. EBWs were generated using Hadlock and IG-21 formulas. The gestation-adjusted projection method determined a projected EBW at delivery, which was compared to actual birthweight (ABW). Intraclass correlation coefficient (ICC) assessed agreement. The proportion of EBWs correct within 10% of ABW predicted by each formula were compared using McNemar's test. This study had 90% power for a non-inferiority margin of 5% for comparing accuracy within 10% of ABW between methods. 
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Methods:
The cohort consisted of 31,143 children born Appropriate for Gestational Age (AGA) with a non-smoking mother (AGA NS), 1926 born Small for Gestational Age (SGA) with non-smoking mother (SGA NS) and 173 born SGA with smoking mother (SGA S). Intrauterine exposure to smoking was defined as maternal smoking at gestational week 32. Data on height and weight were collected at birth, age 1.5, 3, 4 and 5 years. A generalised linear mixed effect model adjusted for relevant fetal, maternal and early childhood confounders was conducted. Logistic regression models were used to evaluate risk of short stature (<10 th percentile) at 1.5 and 5 years of age. Risks are presented as relative risks (RR) with 95% confidence intervals (CI). Results: There was no significant difference in birth length or birth weight between children born SGA NS and SGA S (p=0.083 and p=0.519, respectively).
At [19.5;20 .1], respectively).
At both 1.5 and 5 years of age, children born SGA NS had increased risk of short stature compared with children born AGA NS (RR 3.2 [95% CI 2.6; 3.8] and 1.6 [1.4; 1.9]). Children born SGA S did not have an association with short stature. Conclusions: Children born SGA with smoking mother have a more rapid catch-up growth than children with non-smoking mother, even after adjustment for confounders, including breast-feeding habits.
Being born SGA S is not associated with increased risk of short stature at 1.5 or 5 years of age, which SGA NS is.
